Clinical trial
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation…
NCT00212810 · Ortho-McNeil Neurologics, Inc., Industry · Completed
Key facts
| NCT number | NCT00212810 |
|---|---|
| Title | Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache. |
| Official title | TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study |
| Lead sponsor | Ortho-McNeil Neurologics, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Migraine, Headache, Classic Migraine, Common Migraine |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 385 |
| Start date | Sep 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: